Sign Up to like & get
recommendations!
1
Published in 2023 at "ACS medicinal chemistry letters"
DOI: 10.1021/acsmedchemlett.2c00454
Abstract: Protein tyrosine phosphatase SHP2 is an oncogenic protein that can regulate different cytokine receptor and receptor tyrosine kinase signaling pathways. We report here the identification of a novel series of SHP2 allosteric inhibitors having an…
read more here.
Keywords:
novel series;
discovery novel;
potent shp2;
shp2 allosteric ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "ACS medicinal chemistry letters"
DOI: 10.1021/acsmedchemlett.3c00059
Abstract: Src homology 2-containing protein tyrosine phosphatase 2 (SHP2) is the first reported nonreceptor oncogenic tyrosine phosphatase connecting multiple signal transduction cascades and exerting immunoinhibitory function through the PD-1 checkpoint receptor. As part of a drug…
read more here.
Keywords:
novel series;
discovery novel;
series;
potent shp2 ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Journal of Enzyme Inhibition and Medicinal Chemistry"
DOI: 10.1080/14756366.2022.2151594
Abstract: Abstract The non-receptor protein tyrosine phosphatase (PTP) SHP2 encoded by the PTPN11 gene is a critical regulator in a number of cellular signalling processes and pathways, including the MAPK and the immune-inhibitory programmed cell death…
read more here.
Keywords:
amino methyl;
shp2;
allosteric inhibitor;
shp2 allosteric ... See more keywords